COVID-19 Bad For Smaller Companies, Good For Innovation: Experts
Executive Summary
Medtech experts say despite the hardships many manufacturers are facing due to the coronavirus pandemic, there are opportunities depending on the kind of company.
You may also be interested in...
Medtronic CEO Regrets Not Moving More Aggressively On Some M&A Deals During Pandemic
Geoff Martha says the COVID-19 pandemic didn’t create the kind of liquidity crisis that would have allowed bigger companies to get bargain deals on smaller medtech firms.
Massive Family Dollar Rat Infestation Leads To Multi-State Recall
The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.
Digital Health Roundup: Exec Chats With Illumina, Bloom, AngelMed; M&A, Funding; FDA Down-Classifies Apps
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights IBM Watson Health’s divestiture and other financing news, Exec Chats with Illumina, AngelMed and Bloom, Philips’ new hand-held ultrasound device and autonomous robotic surgery, as well as the latest FDA news on digital health.